Effect of Carboplatin on Rat Spermatogenesis

Urologia Internationalis

Volumn 56, Issue 4, 1996, Pages 219-223

  Fuse, Hideki ^a   Fujiuchi, Yasuyoshi ^a   Junicho, Akira ^a   Iwasaki, Masashi ^a   Katayama, Takashi ^a  

^a TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Carboplatin; Rat; Spermatogenesis

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CARBOPLATIN; FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DOSE RESPONSE; EPIDIDYMIS; FOLLITROPIN BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; LEYDIG CELL; LUTEINIZING HORMONE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEMINIFEROUS TUBULE; SERTOLI CELL; SPERMATOGENESIS; SPERMATOGONIUM; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; TESTIS FUNCTION; TESTOSTERONE BLOOD LEVEL;

EID: 0030010131     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000282846     Document Type: Article

References (20)

1. Corden BJ, Fine RL, Ozols RF, Collins JM: Clinical pharmacology of high dose cisplatin. Cancer Chemother Pharmacol 1985;14:38-41.
2. Walsh TJ, Clark AW, Parhad IM, Green WR: Ncurotoxic effects of cisplatin therapy. Arch Neurol 1982:39:719-720.
3. Lochrcr JP, Einhorn LH: Cisplatin. Ann Intern Med 1984:100:704-713.
4. Von Hoff DD, Schilsky R, Reichert CM, Reddick RL, Rozencweig M, Young RC, Muggia FM: Toxic effects of cis-dichlorodiammine-platinum (II) in man. Cancer Treat Rep 1979; 63:1527-1531.
5. Harrap KR, Jones M, Wilkinson CR, Clink HM, Sparrow S, Mitchley BCV, Clarke S, Vea-scy A: Antitumor, toxic and biochemical properties of cisplatin and eight other platinum complexes. Dev Oncol 1984:17:193-212.
6. Rose WC, Schurig JE, Ilaftalen JB, Bradncr WT: Antitumor activity and toxicity of cisplatin analogs. Cancer Treat Rep 1982:66:135-146.
7. Canetta R, Bragman K, Smaldone L, Rozencweig M: Carboplatin: Current status and future prospects. Cancer Treat Rev 1988; 15(supplB): 17-32.
8. Alberts DS, Mason-Liddil N: Carboplatin in the treatment of ovarian cancer. Semin Oncol 1989:16:19-26.
9. Bunn PA: Review of therapeutic trials of carboplatin in lung cancer. Semin Oncol 1989:16: 27-33.
10. Mangionc C, Bolis G, Pccorclli S, Bragman K, Epis A, Favalli G, Gambino A, Landoni F, Presti M, Torri W, Vassena L, Zanaboni F, Marsoni S: Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin. J Natl Cancer Inst 1989:81:1464-1471.
11. Carreau S, Papadopoulos V, Boujrad N, Dros-dowsky MA: Effects of cisplatin and bleomycin on mature rat Lcvdig cell testosterone production. J Steroid Biochem 1988:30:449-451.
12. Leblond CP, Clermont Y: Spermatogenesis of rat. mouse, hamster and guinea pig as revealed by the 'periodic acid fuchsin sulfurous acid' technique. Am J Anat 1952:90:167-215.
13. Hansen PV, Trykker H, Helkjaer PE, Andersen J: Testicular function in patients with testicular cancer treated with orchiectomy alone or orchiectomy plus cisplatin-bascd chemotherapy. J Natl Cancer Inst 1989:81:1246-1249.
14. Vawda AI, Davies AG: Effects of cisplatin on the mouse testis. Acta Endocrinol 1986:112 436-441.
15. Vawda AI: Effect of testosterone on cisplatin induced testicular damage. Arch Androl 1994 32:53-57.
16. Huang HFS, Pogach I.M, Nathan E, Giglio W Acute and chronic effects of cisplatinum upon testicular function in the rat. J Androl 1990; 11 436-445.
17. Kôpf-Maicr P: Effects of carboplatin on the testis. A histological study. Cancer Chemother Pharmacol 1992;29:227-235.
18. Clermont Y, Harvey SC: Duration of the cycle of the seminiferous epithelium of normal, hv-pophysectomizcd hormone-treated albino rats. Endocrinology 1965:76:80-89.
19. Arnarn RP, Johnson L, Thompson DL Jr, Picket BW: Daily spermatozoal reserves and transit time of spermatozoa through the epididymis of the rhesus monkey. Biol Reprod 1976;15:586-592.
20. Lint VS, Fang VS: Gonadal dysfunction in uremic men. A study of the hypothalamic-pitu-itary-iesticular axis before and after renal transplantation. Am J Med 1975:58:655-662.